Alembic gets US FDA nod for Bromfenac Ophthalmic Solution, 0.07 per cent EP News Bureau Jul 9, 2024 The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Prolensa Ophthalmic Solution, 0.07 per…
